These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23678592)

  • 1. [Therapeutic goal and pharmacotherapy according to clinical stages of schizophrenia].
    Furuhashi K; Iwata N
    Nihon Rinsho; 2013 Apr; 71(4):635-40. PubMed ID: 23678592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The significance of the early detection and intervention for schizophrenia].
    Takeshi K; Yamaguchi T; Mizuno M
    Nihon Rinsho; 2013 Apr; 71(4):630-4. PubMed ID: 23678591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - preliminary results.
    Novak Sarotar B; Pesek MB; Agius M; Kocmur M
    Neuro Endocrinol Lett; 2008 Dec; 29(6):990-4. PubMed ID: 19112411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relapse: causes and consequences].
    Thomas P
    Encephale; 2013 Sep; 39 Suppl 2():S79-82. PubMed ID: 24084426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of untreated psychosis and it's effect on the functional outcome in schizophrenia - preliminary results.
    Sarotar BN; Pesek MB; Agius M; Pregelj P; Kocmur M
    Psychiatr Danub; 2008 Jun; 20(2):179-83. PubMed ID: 18587288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is our clinical practice of antipsychotic relapse prevention in schizophrenia really evidence-based].
    Schanda H; Stompe T
    Neuropsychiatr; 2010; 24(1):14-26. PubMed ID: 20146916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.
    Altamura AC; Bobo WV; Meltzer HY
    Int Clin Psychopharmacol; 2007 Sep; 22(5):249-67. PubMed ID: 17690594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-episode schizophrenia: the importance of early intervention and subjective tolerability.
    Kasper S
    J Clin Psychiatry; 1999; 60 Suppl 23():5-9. PubMed ID: 10625193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacotherapy of schizophrenia spectrum disorders: State of the Art].
    Eich PE; Nick B
    Ther Umsch; 2018 Jun; 75(1):9-17. PubMed ID: 29909763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of untreated psychosis and the long-term course of schizophrenia.
    de Haan L; van Der Gaag M; Wolthaus J
    Eur Psychiatry; 2000 Jun; 15(4):264-7. PubMed ID: 10951611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modification of long-term schizophrenia by somato-therapeutic measures].
    Gross G; Huber G; Schüttler R
    Psychiatr Clin (Basel); 1980; 13(3-4):179-92. PubMed ID: 6113621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Longterm treatment of schizophrenia].
    Pajonk VF
    MMW Fortschr Med; 2006 Jan; 148(4):35-8. PubMed ID: 16502798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome measures in early psychosis; relevance of duration of untreated psychosis.
    Singh SP
    Br J Psychiatry Suppl; 2007 Aug; 50():s58-63. PubMed ID: 18019046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication.
    de Haan L; Linszen DH; Lenior ME; de Win ED; Gorsira R
    Schizophr Bull; 2003; 29(2):341-8. PubMed ID: 14552508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management strategies for the treatment of schizophrenia.
    Kane JM
    J Clin Psychiatry; 1999; 60 Suppl 12():13-7. PubMed ID: 10372604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between patient satisfaction and treatment outcomes in schizophrenia.
    Chue P
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):38-56. PubMed ID: 17046986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early, targeted pharmacotherapeutic intervention in schizophrenia.
    Carpenter W
    J Clin Psychiatry; 1986 May; 47 Suppl():23-9. PubMed ID: 2871012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.